Apogem Capital’s BioCryst Pharmaceuticals BCRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q3
Sell
-13,219
Closed -$140K 135
2022
Q2
$140K Buy
+13,219
New +$140K 0.13% 140